⌘K
Loading ticker…
Rhythm Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) has a 3-month relative strength percentile of 83 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 59. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 5.1%, relative volume 3.05×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 83, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RYTM is held by 8 ETFs as of Mar 2026. Top owner: VTI at 0.01% weight, $189M notional. Top 3 carry $439M.
Top 8 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.01% | $189M |
| VBVanguard Small Cap ETF | 0.08% | $137M |
| IWMiShares Russell 2000 ETF | 0.16% | $112M |
| XBIState Street SPDR S&P Biotech ETF | 1.10% | $82M |
| VBKVanguard Small-Cap Growth ETF | 0.20% | $77M |
| VXFVanguard Extended Market ETF | 0.07% | $59M |
| IWOiShares Russell 2000 Growth ETF | 0.31% | $38M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.01% | $7M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RYTM Jan avg: -2.05% median: -4.13% win: 25% σ: 5.55% n: 4 2022-04-12 → 2026-05-29 | RYTM Feb avg: -7.46% median: -8.58% win: 0% σ: 4.18% n: 4 2022-04-12 → 2026-05-29 | RYTM Mar avg: -9.14% median: -4.87% win: 0% σ: 11.91% n: 4 2022-04-12 → 2026-05-29 | RYTM Apr avg: -1.77% median: -6.45% win: 40% σ: 20.70% n: 5 2022-04-12 → 2026-05-29 | RYTM May avg: -14.02% median: -10.26% win: 20% σ: 19.77% n: 5 2022-04-12 → 2026-05-29 | RYTM Jun avg: 9.43% median: 9.06% win: 75% σ: 10.13% n: 4 2022-04-12 → 2026-05-29 (current) | RYTM Jul avg: 66.02% median: 26.15% win: 100% σ: 92.39% n: 4 2022-04-12 → 2026-05-29 | RYTM Aug avg: 36.07% median: 33.41% win: 75% σ: 34.82% n: 4 2022-04-12 → 2026-05-29 | RYTM Sep avg: 1.31% median: 3.16% win: 50% σ: 10.41% n: 4 2022-04-12 → 2026-05-29 | RYTM Oct avg: 1.82% median: 1.77% win: 75% σ: 8.83% n: 4 2022-04-12 → 2026-05-29 | RYTM Nov avg: 19.22% median: 18.17% win: 75% σ: 22.15% n: 4 2022-04-12 → 2026-05-29 | RYTM Dec avg: 8.66% median: 3.45% win: 50% σ: 20.68% n: 4 2022-04-12 → 2026-05-29 |